Cai F, Yang X, Ma G, Wang P, et al. EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-kappaB signalling activation independent of hydroxylase activity. Br J Cancer 2024 Jan 6. doi: 10.1038/s41416-023-02546.
PMID: 38184692